The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
PAAB Quarterly Forum Review - Q4/2025
Blogs
1
Posts
1
Posters
12
Views
1
Watching
-
Happy New Year @Manufacturer and @Agency
This year is PAAB's 50th Anniversary! Stay tuned for treats throughout the year to celebrate this milestone. We're starting with:
ARO expansion + Client Messenger Service - Free with all ARO in Q1 to celebrate PAAB's 50th Anniversary
Learn more here.The 2025 PAAB Q4 Forum Quarterly Review is now live!
Some of the things that you might want to check out:
- AI Assisted Submission Process - Call for volunteers
- Attention Icon Update
- Expansion for Rare Diseases
- Creative Imagery Document Posted
- Protecting the Integrity of PAAB Resources
Coming in 2026: New service offerings, anonymous advertising reporting system and more...
As always, thoughts and feedback are welcome below
.
Thank you
PAAB
